# 2025-21407: FDA Backs Off Asbestos Tests in Talc Cosmetics Amid Pushback

2025-21407, Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal, is a Federal Register proposed rule from Health and Human Services Department, Food and Drug Administration published 2025-11-28, effective 2025-11-28; deemed significant under Executive Order 12866 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-21407
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-21407
- Title: Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal
- Type: Proposed Rule
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 54603
- Published: 2025-11-28
- Effective: 2025-11-28
- Comments close: not stated
- Significant: yes (FR_METADATA)
- Touches household money: no
- Regulation identifier numbers: 0910-AI82
- Last updated: 2026-06-08

## In one line

FDA Backs Off Asbestos Tests in Talc Cosmetics Amid Pushback

## Summary

The FDA is hitting pause and withdrawing its plan to require specific tests for asbestos in talc-based cosmetics after hearing lots of feedback. This affects cosmetic makers who would have had to test and keep records to keep their products safe and legal. No new rules or costs are coming right now, but the FDA will rethink and revisit this soon.

## Abstract

The Food and Drug Administration (FDA, Agency, or we) is announcing the withdrawal of the proposed rule entitled "Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products," which published in the Federal Register of December 27, 2024. FDA is taking this action in response to comments received during the comment period for the proposed rule that warrant further consideration and assessment prior to issuing final regulations to establish and require standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products pursuant to the Modernization of Cosmetics Regulation Act of 2022.

## Effects PRIA read

- Testing/Recordkeeping Requirement Withdrawn: benefit, medium. If you make talc-containing cosmetics, the FDA has withdrawn the December 27, 2024 proposed rule that would have required you to test talc or talc-containing products for asbestos and keep records. The withdrawal is effective November 28, 2025, so those specific testing and recordkeeping obligation…
- Consumers Not Covered By Proposed Tests Now: cost, medium. Because the FDA withdrew the December 27, 2024 proposed rule on November 28, 2025, users of talc-containing cosmetic products are not covered today by any standardized testing requirement the proposal would have created. The Agency said it will reconsider how to reduce asbestos exposure in talc-con…
- FDA Will Issue New Proposed Rule Later: cost, medium. The FDA said it will issue a new proposed rule to meet its obligations under section 3505 of the Modernization of Cosmetics Regulation Act of 2022. Manufacturers should expect the Agency to revisit standardized asbestos testing in talc-containing cosmetics after further consideration.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-21407 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/28/2025-21407/testing-methods-for-detecting-and-identifying-asbestos-in-talc-containing-cosmetic-products)
- [2025-21407 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-28/pdf/2025-21407.pdf)

## Related
- [Previous: 2025-21346, Air Plan Approval; Missouri; Reporting Emission Data, Emission Fees, and Proces…](https://policyrisk.com/federal-register/2025-21346)
- [Next: 2025-21409, Airworthiness Directives; Schempp-Hirth Flugzeugbau GmbH Gliders](https://policyrisk.com/federal-register/2025-21409)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-21407 (as of 2026-06-08).
